论文信息 - Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells - 字舞流文

Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells

S. Sebens | H. Oberg | D. Kabelitz | M. Peipp | M. Gramatzki | D. Bauerschlag | D. Wesch | C. Kellner | D. Gonnermann